EV/EBITDA
-0.51
-0.01-2.00%
Fri, 07 Feb 2025 21:00:00 GMT
Summary
- As of February 8, 2025, VYNE EV/EBITDA is -0.51, with a fall of -0.01 (-2.00%) during the most recent trading day.
- Over the past year, VYNE EV/EBITDA has dropped by -0.46 (-920.00%).
- VYNE EV/EBITDA is now -162.20% below its all-time high of 0.82.
Performance
VYNE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
VYNE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -2.0% | +4.0% | +2.1% |
| 1 m1 month | +59.2% | -59.0% | -44.0% |
| 3 m3 months | +35.4% | -34.7% | -22.5% |
| 6 m6 months | -563.6% | +677.9% | +36.2% |
| ytdytd | +36.3% | -36.0% | -23.5% |
| 1 y1 year | -920.0% | +1231.2% | +6.6% |
| 5 y5 years | +59.5% | -79.7% | -99.3% |
VYNE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -6.3% | -1.25 | +59.2% | |
| 3 m | 3-month | -0.48 | -6.3% | -1.25 | +59.2% |
| 6 m | 6-month | 0.19 | -368.4% | -1.25 | +59.2% |
| 1 y | 1-year | 0.19 | -368.4% | -1.25 | +59.2% |
| 3 y | 3-year | 0.82 | -162.2% | -1.41 | +63.8% |
| 5 y | 5-year | 0.82 | -162.2% | -3.86 | +86.8% |
| alltime | all time | 0.82 | -162.2% | -29.03 | +98.2% |
VYNE Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.51(-36.3%) |
| 2024 | -0.80(+900.0%) |
| 2023 | -0.08(-112.1%) |
| 2022 | 0.66(-300.0%) |
| Date | Value |
|---|---|
| 2021 | -0.33(-67.0%) |
| 2020 | -1.00(-45.7%) |
| 2019 | -1.84(+20.3%) |
| 2018 | -1.53 |
FAQ
- What is VYNE Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for VYNE Therapeutics?
- What is VYNE EV/EBITDA year-to-date change?
- What is VYNE Therapeutics EV/EBITDA year-on-year change?
What is VYNE Therapeutics EV/EBITDA?
The current EV/EBITDA of VYNE is -0.51
What is the all time high EV/EBITDA for VYNE Therapeutics?
VYNE Therapeutics all-time high EV/EBITDA is 0.82
What is VYNE EV/EBITDA year-to-date change?
VYNE Therapeutics EV/EBITDA has changed by +0.29 (+36.25%) since the beginning of the year
What is VYNE Therapeutics EV/EBITDA year-on-year change?
Over the past year, VYNE EV/EBITDA has changed by -0.46 (-920.00%)